Učitavanje...
IMMU-05. CSF METABOLOMICS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH BRAIN METASTASIS RECEIVING IMMUNOTHERAPY
INTRODUCTION: Checkpoint inhibitors show a positive intracranial response in around 20–50% of patients with metastatic melanoma and non-small cell lung cancer (NSCLC). There is a current paucity of biomarkers to prospectively identify these patients. We hypothesize that CSF would provide useful data...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7651074/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.436 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|